These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 7568331)
1. The search for synergy: a critical review from a response surface perspective. Greco WR; Bravo G; Parsons JC Pharmacol Rev; 1995 Jun; 47(2):331-85. PubMed ID: 7568331 [No Abstract] [Full Text] [Related]
2. [Pharmacodynamic interaction model and its clinical application]. Tang M; Zhang W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):692-6. PubMed ID: 19634700 [TBL] [Abstract][Full Text] [Related]
3. Synergy, additivism and antagonism in immunosuppression. A critical review. Berenbaum MC Clin Exp Immunol; 1977 Apr; 28(1):1-18. PubMed ID: 324671 [No Abstract] [Full Text] [Related]
4. A system of models for the action of drugs applied singly or jointly to biological organisms. Ashford JR; Cobby JM Biometrics; 1974 Mar; 30(1):11-31. PubMed ID: 4813377 [No Abstract] [Full Text] [Related]
5. Fitting models for the joint action of two drugs using SAS. Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217 [TBL] [Abstract][Full Text] [Related]
6. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119 [TBL] [Abstract][Full Text] [Related]
7. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions. Meletiadis J; te Dorsthorst DT; Verweij PE Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706 [TBL] [Abstract][Full Text] [Related]
8. Hypnotic and opioid anesthetic drug interactions on the CNS, focus on response surface modeling. Bouillon TW Handb Exp Pharmacol; 2008; (182):471-87. PubMed ID: 18175105 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of combined drug action]. Xu DZ Sheng Li Ke Xue Jin Zhan; 1992 Jul; 23(3):248-53. PubMed ID: 1299964 [No Abstract] [Full Text] [Related]
10. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Jonker DM; Voskuyl RA; Danhof M Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245 [TBL] [Abstract][Full Text] [Related]
11. Assessment of synergistic and antagonistic effects of chemotherapeutic agents in vitro. Chou TC Contrib Gynecol Obstet; 1994; 19():91-107. PubMed ID: 7995057 [No Abstract] [Full Text] [Related]
12. Robustness of choice of number of doses for maximum likelihood estimation of the ED(50) in bioassay. Huang Y Stat Med; 2002 Aug; 21(15):2215-23. PubMed ID: 12210634 [TBL] [Abstract][Full Text] [Related]
13. A Bayesian approach to a logistic regression model with incomplete information. Choi T; Schervish MJ; Schmitt KA; Small MJ Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482 [TBL] [Abstract][Full Text] [Related]
14. Advances in modeling of biomolecular interactions. Cai CZ; Li ZR; Wang WL; Chen YZ Acta Pharmacol Sin; 2004 Jan; 25(1):1-8. PubMed ID: 14704115 [TBL] [Abstract][Full Text] [Related]
15. Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Shafer SL; Hendrickx JF; Flood P; Sonner J; Eger EI Anesth Analg; 2008 Aug; 107(2):507-24. PubMed ID: 18633029 [TBL] [Abstract][Full Text] [Related]
16. Quantification of hurdles: predicting the combination of effects -- Interaction vs. non-interaction. Bidlas E; Lambert RJ Int J Food Microbiol; 2008 Nov; 128(1):78-88. PubMed ID: 18703251 [TBL] [Abstract][Full Text] [Related]